[1]廉永琪,朱淑芬.脓毒症相关肠道微生态作用机制研究进展[J].陕西医学杂志,2024,(12):1721-1725.[doi:DOI:10.3969/j.issn.1000-7377.2024.12.028]
 LIAN Yongqi,ZHU Shufen.Advances in mechanism of action of sepsis-associated intestinal microecology[J].,2024,(12):1721-1725.[doi:DOI:10.3969/j.issn.1000-7377.2024.12.028]
点击复制

脓毒症相关肠道微生态作用机制研究进展
分享到:

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
期数:
2024年12期
页码:
1721-1725
栏目:
综 述
出版日期:
2024-12-05

文章信息/Info

Title:
Advances in mechanism of action of sepsis-associated intestinal microecology
作者:
廉永琪朱淑芬
(内蒙古医科大学附属医院重症医学科,内蒙古 呼和浩特 010030)
Author(s):
LIAN YongqiZHU Shufen
(Department of Critical Care Medicine,the Affiliated Hospital of Inner Mongolia Medical University,Hohhot 010030,China)
关键词:
脓毒症 肠道微生态 肠道屏障 免疫抑制 器官障碍 微生物疗法
Keywords:
Sepsis Intestinal microecology Intestinal barrier Immunosuppression Organ disorders Microbial therapy
分类号:
R 459.7
DOI:
DOI:10.3969/j.issn.1000-7377.2024.12.028
文献标志码:
A
摘要:
脓毒症是一种因宿主对感染的反应异常进而引发多器官功能衰竭的综合征,对人类健康构成严重威胁。肠道微生态在维持肠道屏障稳定和调节免疫等方面发挥重要作用,并参与了危重疾病的发生和发展。肠道微生态在脓毒症发生前发生变化,这种改变可通过改变肠道通透性、启动炎症及免疫反应等不同机制调控脓毒症的进展。此外,肠道微生态的紊乱还对脓毒症相关性器官功能损伤产生深远影响,如加重多器官功能障碍综合征,尤其是对肺、肾和脑等重要器官的损伤。现对脓毒症相关肠道微生态作用机制的研究现状进行综述,通过深入了解肠道微生态与脓毒症之间的复杂关系为脓毒症提供新的治疗思路。
Abstract:
Sepsis is a syndrome characterized by dysregulated host responses to infection,leading to multiple organ failure and posing a significant threat to human health.The gut microbiota plays a crucial role in maintaining intestinal barrier stability and regulating immune functions,thereby contributing to the development and progression of critical illnesses.Changes in the gut microbiota occur before the onset of sepsis,and these changes can regulate the progression of sepsis through various mechanisms,including altering intestinal permeability,initiating inflammatory responses,and modulating immune reactions.Additionally,dysregulation of the gut microbiota profoundly impacts organ dysfunction associated with sepsis,exacerbating conditions such as multiple organ dysfunction syndrome,particularly affecting vital organs like the lungs,kidneys,and brain.This review aims to summarize the current research on the mechanisms by which the gut microbiota influences sepsis.By gaining a deeper understanding of the complex relationship between gut microbiota and sepsis,we aim to provide new therapeutic insights and strategies for the treatment of sepsis.

参考文献/References:

[1] SINGER M,DEUTSCHMAN C S,SEYMOUR C W,et al.The third international consensus definitions for sepsis and septic shock(sepsis-3)[J].JAMA,2016,315(8):801-810.
[2] ADELMAN M W,WOODWORTH M H,LANGELIER C,et al.The gut microbiome's role in the development,maintenance,and outcomes of sepsis[J].Crit Care,2020,24(1):278.
[3] 赵萌,杨轶童,李翰文,等.肠道微生物菌群与川崎病关系研究进展[J].陕西医学杂志,2024,53(2):270-273,281.
[4] XIANG Q,YAN X,SHI W,et al.Early gut microbiota intervention in premature infants:Application perspectives[J].J Adv Res,2023,51:59-72.
[5] SUN S,WANG D,DONG D,et al.Altered intestinal microbiome and metabolome correspond to the clinical outcome of sepsis[J].Crit Care,2023,27(1):127.
[6] YOU J,BI X,ZHANG K,et al.Causal associations between gut microbiota and sepsis:A two-sample mendelian randomization study[J].Eur J Clin Invest,2023,53(11):e14064.
[7] AGUDELO-OCHOA G M,VALDÉS-DUQUE B E,GIRALDO-GIRALDO N A,et al.Gut microbiota profiles in critically ill patients,potential biomarkers and risk variables for sepsis[J].Gut Microbes,2020,12(1):1707610.
[8] RAMIREZ J,GUARNER F,BUSTOS FERNANDEZ L,et al.Antibiotics as major disruptors of gut microbiota[J].Front Cell Infect Microbiol,2020,10:572912.
[9] GRASPEUNTNER S,WASCHINA S,KÜNZEL S,et al.Gut dysbiosis with bacilli dominance and accumulation of fermentation products precedes late-onset sepsis in preterm infants[J].Clin Infect Dis,2019,69(2):268-277.
[10] NIU M,CHEN P.Crosstalk between gut microbiota and sepsis[J].Burns Trauma,2021,9:tkab036.
[11] WU X X,HUANG X L,CHEN R R,et al.Paeoniflorin prevents intestinal barrier disruption and inhibits lipopolysaccharide(LPS)-induced inflammation in Caco-2 cell monolayers[J].Inflammation,2019,42(6):2215-2225.
[12] DI SABATINO A,SANTACROCE G,ROSSI C M,et al.Role of mucosal immunity and epithelial-vascular barrier in modulating gut homeostasis[J].Intern Emerg Med,2023,18(6):1635-1646.
[13] 江娟,李静,夏可,等.反复肺炎患儿肠道菌群与免疫功能指标变化及相关性研究[J].陕西医学杂志,2023,52(9):1200-1203.
[14] LESNIAK N A,SCHUBERT A M,FLYNN K J,et al.The gut bacterial community potentiates clostridioides difficile infection severity[J].mBio,2022,13(4):e0118322.
[15] 王婷,韦小碗,杨亮,等.脓毒症患者血清PCT、CRP、IL-6和IL-10水平检测及临床意义[J].陕西医学杂志,2020,49(11):1510-1514.
[16] LI S,WANG C,ZHANG C,et al.Evaluation of the effects of different bacteroides vulgatus strains against DSS-induced colitis[J].J Immunol Res,2021,2021:9117805.
[17] YANG Y,MA Q,WANG Q,et al.Mannose enhances intestinal immune barrier function and dextran sulfate sodium salt-induced colitis in mice by regulating intestinal microbiota[J].Front Immunol,2024,15:1365457.
[18] LECCESE G,BIBI A,MAZZA S,et al.Probiotic lactobacillus and bifidobacterium strains counteract adherent-invasive escherichia coli(AIEC)virulence and hamper IL-23/Th17 axis in ulcerative colitis,but not in Crohn's disease[J].Cells,2020,9(8):1824.
[19] WILMORE J R,GAUDETTE B T,GOMEZ ATRIA D,et al.Commensal microbes induce serum IgA responses that protect against polymicrobial sepsis[J].Cell Host Microbe,2018,23(3):302-311.e3.
[20] SPENCER J,KLAVINSKIS L S,FRASER L D.The human intestinal IgA response,burning questions[J].Front Immunol,2012,3:108.
[21] LIU P,WANG Y,YANG G,et al.The role of short-chain fatty acids in intestinal barrier function,inflammation,oxidative stress,and colonic carcinogenesis[J].Pharmacol Res,2021,165:105420.
[22] PARADA VENEGAS D,DE LA FUENTE M K,LANDSKRON G,et al.Short chain fatty acids(SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases[J].Front Immunol,2019,10:277.
[23] KINASHI Y,HASE K.Partners in leaky gut syndrome:Intestinal dysbiosis and autoimmunity[J].Front Immunol,2021,12:673708.
[24] XU J,LIANG R,ZHANG W,et al.Faecalibacterium prausnitzii-derived microbial anti-inflammatory molecule regulates intestinal integrity in diabetes mellitus mice via modulating tight junction protein expression[J].J Diabetes,2020,12(3):224-236.
[25] CHEN J,HALL S,VITETTA L.Altered gut microbial metabolites could mediate the effects of risk factors in Covid-19[J].Rev Med Virol,2021,31(5):1-13.
[26] ZHOU X,LIAO Y.Gut-lung crosstalk in sepsis-induced acute lung injury[J].Front Microbiol,2021,12:779620.
[27] ALGHETAA H,MOHAMMED A,ZHOU J,et al.Resveratrol-mediated attenuation of superantigen-driven acute respiratory distress syndrome is mediated by microbiota in the lungs and gut[J].Pharmacol Res,2021,167:105548.
[28] SHAH N,RABB H.Intestinal microbiota in experimental acute kidney injury[J].Nephron,2023,147(1):25-30.
[29] YANG J,JI G E,PARK M S,et al.Probiotics partially attenuate the severity of acute kidney injury through an immunomodulatory effect[J].Kidney Res Clin Pract,2021,40(4):620-633.
[30] LEE J,LEE J,KIM K,et al.Antibiotic-induced intestinal microbiota depletion can attenuate the acute kidney injury to chronic kidney disease transition via NADPH oxidase 2 and trimethylamine-N-oxide inhibition[J].Kidney Int,2024,105(6):1239-1253.
[31] LI Z,ZHANG F,SUN M,et al.The modulatory effects of gut microbes and metabolites on blood-brain barrier integrity and brain function in sepsis-associated encephalopathy[J].Peer J,2023,11:e15122.
[32] 田永超.脓毒症肠黏膜屏障功能障碍防治研究进展[J].陕西医学杂志,2020,49(4):510-513.
[33] BONTEN M.Selective decontamination of the digestive tract:An answer at last?[J].JAMA,2022,328(23):2310-2311.
[34] HE S,LIN F,HU X,et al.Gut microbiome-based therapeutics in critically ill adult patients-a narrative review[J].Nutrients,2023,15(22):4734.
[35] ZHANG L,SHI X,QIU H,et al.Protein modification by short-chain fatty acid metabolites in sepsis:A comprehensive review[J].Front Immunol,2023,14:1171834.

相似文献/References:

[1]尤金枝,王捷虹,高麦仓△,等.尿激酶、低分子肝素对脓毒症弥散性血管内凝血大鼠模型的影响研究*[J].陕西医学杂志,2020,49(9):1071.[doi:DOI:10.3969/j.issn.1000-7377.2020.09.004]
 YOU Jinzhi,WANG Jiehong,GAO Maicang,et al.Study of urokinase and low molecular weight heparin on sepsis DIC rats model[J].,2020,49(12):1071.[doi:DOI:10.3969/j.issn.1000-7377.2020.09.004]
[2]杨晓英,顾华杰,戴晓勇,等.重症超声在脓毒症机械通气患者撤机中的评估价值*[J].陕西医学杂志,2020,49(9):1094.[doi:DOI:10.3969/j.issn.1000-7377.2020.09.010]
 YANG Xiaoying,GU Huajie,DAI Xiaoyong,et al.Evaluation value of severe ultrasound in weaning of sepsis patients with mechanical ventilation[J].,2020,49(12):1094.[doi:DOI:10.3969/j.issn.1000-7377.2020.09.010]
[3]魏东梅,邵龙刚.芒柄花黄素对脓毒症小鼠炎性反应及MAPK/NF-κB通路影响的实验研究[J].陕西医学杂志,2023,52(5):503.[doi:DOI:10.3969/j.issn.1000-7377.2023.05.002]
 WEI Dongmei,SHAO Longgang.Effects of formononetin on inflammatory response and MAPK/NF-κB pathway in septic mice[J].,2023,52(12):503.[doi:DOI:10.3969/j.issn.1000-7377.2023.05.002]
[4]王 英,胡占升,张晓玉,等.Maresin 1对脓毒症相关急性肾损伤的保护作用及机制实验研究[J].陕西医学杂志,2023,52(7):809.[doi:DOI:10.3969/j.issn.1000-7377.2023.07.007]
 WANG Ying,HU ZhanSheng,ZHANG Xiaoyu,et al.Experimental study on the protective effect of Maresin 1 on sepsis-associated acute kidney injury and its mechanism[J].,2023,52(12):809.[doi:DOI:10.3969/j.issn.1000-7377.2023.07.007]
[5]王 浩,高春美.外周血单核细胞Toll样受体/核转录因子-κB信号通路分子表达水平与血液透析合并血液感染患者病情严重程度相关性分析[J].陕西医学杂志,2023,52(7):875.[doi:DOI:10.3969/j.issn.1000-7377.2023.07.023]
 WANG Hao,GAO Chunmei.Correlation between expression levels of TLRs/NF-κB signaling pathway molecules in peripheral blood mononuclear cells and disease severity of patients with hemodialysis and bloodstream infection[J].,2023,52(12):875.[doi:DOI:10.3969/j.issn.1000-7377.2023.07.023]
[6]谢琼燕,许环清,叶 文,等.生物标志物预测脓毒症引发急性肾损伤临床研究[J].陕西医学杂志,2023,52(7):880.[doi:DOI:10.3969/j.issn.1000-7377.2023.07.024]
 XIE Qiongyan,XU Huanqing,YE Wen,et al.Clinical study of using biomarkers to predict acute kidney injury induced by sepsis[J].,2023,52(12):880.[doi:DOI:10.3969/j.issn.1000-7377.2023.07.024]
[7]刘广精,王光权,黎天皇.乌司他丁联合依诺肝素治疗脓毒症并发急性肺损伤临床疗效及安全性研究[J].陕西医学杂志,2023,52(8):1071.[doi:DOI:10.3969/j.issn.1000-7377.2023.08.030]
 LIU Guangjing,WANG Guangquan,LI Tianhuang.Clinical efficacy and safety of ulinastatin combined with enoxaparin in treatment of sepsis complicated with acute lung injury[J].,2023,52(12):1071.[doi:DOI:10.3969/j.issn.1000-7377.2023.08.030]
[8]佘丽萍,王 垚,黄 敏,等.线粒体自噬受体FUNDC1在脓毒症大鼠心肌损伤中对氧化应激响应的调控[J].陕西医学杂志,2025,54(4):441.[doi:DOI:10.3969/j.issn.1000-7377.2025.04.002]
 SHE Liping,WANG Yao,HUANG Min,et al.Regulation of mitochondrial autophagy receptor FUNDC1 in response to oxidative stress in sepsis myocardial injury[J].,2025,54(12):441.[doi:DOI:10.3969/j.issn.1000-7377.2025.04.002]

备注/Memo

备注/Memo:
基金项目:国家自然科学基金资助项目(61865014)
更新日期/Last Update: 2024-12-05